info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received:October 04, 2018; Published: October 17, 2018
DOI: 10.26717/BJSTR.2018.10.001909
Multidrug resistant bacteria are marching and winning. The entire human race is at risk and new, effective antibiotics are needed for survival. Several notable routines to develop novel antibiotics are briefly compared here and possible new strategies are proposed. Key words include but not limited to nanotechnology, metal nanoparticles, natural product, medicinal plants, folk medicine, ethnopharmacology, computer-based screening, synergistic antibacterial activity, genomics, peptides, inhibitor, and structure-based virtual screening.
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Neurology, LA BioMed Research Institute, USA
Endocrinology & Metabolism, Diabetes and Nutrition, Edith Cowan University, Australia
Full Text
PDF
